| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/106689690401200301 |
| P698 | PubMed publication ID | 15306932 |
| P2093 | author name string | John K C Chan | |
| W Cheuk | |||
| P2860 | cites work | Identification of c-MYC as a target of the APC pathway | Q24310637 |
| Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis | Q24317141 | ||
| Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
| Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity | Q24522838 | ||
| TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors | Q24669567 | ||
| Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations | Q24684853 | ||
| Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
| Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
| Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma | Q28250347 | ||
| beta-catenin is a target for the ubiquitin-proteasome pathway | Q29547589 | ||
| Inhibin is not an immunohistochemical marker for hepatocellular carcinoma. An example of the potential pitfall in diagnostic immunohistochemistry caused by endogenous biotin | Q30473108 | ||
| Anaplastic lymphoma kinase expression in inflammatory pseudotumors | Q30676589 | ||
| Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong | Q33919294 | ||
| Effect of formalin tissue fixation and processing on immunohistochemistry | Q33969224 | ||
| Interpretation and quantification of immunostains | Q34425790 | ||
| Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ | Q34459652 | ||
| Clinical management of gastrointestinal stromal tumors: before and after STI-571. | Q34524907 | ||
| Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. | Q34524914 | ||
| Monoclonal antibody therapies in leukemias | Q35007246 | ||
| Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer | Q35177848 | ||
| History of antibody therapy for non-Hodgkin's lymphoma | Q35622590 | ||
| Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma | Q35626359 | ||
| β-Catenin Mutations Are Frequent in Calcifying Odontogenic Cysts, but Rare in Ameloblastomas | Q35843534 | ||
| Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis | Q38455025 | ||
| Signal transduction of beta-catenin | Q40952528 | ||
| Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry | Q42545826 | ||
| ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. | Q42850888 | ||
| Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution | Q43897034 | ||
| Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene | Q44243688 | ||
| ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases | Q44451877 | ||
| Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas | Q44633309 | ||
| Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. | Q44640880 | ||
| Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders | Q47614258 | ||
| Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. | Q51061491 | ||
| Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. | Q53511518 | ||
| Cadherins, catenins and APC in pleural malignant mesothelioma | Q54516140 | ||
| P433 | issue | 3 | |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | 185-206 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | International Journal of Surgical Pathology | Q6051606 |
| P1476 | title | Subcellular localization of immunohistochemical signals: knowledge of the ultrastructural or biologic features of the antigens helps predict the signal localization and proper interpretation of immunostains | |
| P478 | volume | 12 |
| Q37483162 | A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments |
| Q58572626 | Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer |
| Q48312012 | Asymmetric localization of Notch2 on the microvillous surface in choroid plexus epithelial cells |
| Q46963503 | Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report. |
| Q46849118 | CD10 is a characteristic marker of tumours forming morules with biotin-rich, optically clear nuclei that occur in different organs |
| Q37080964 | Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients |
| Q81833801 | Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland |
| Q46522462 | Ligneous conjunctivitis: a clinicopathological, immunohistochemical, and genetic study including the treatment of two sisters with multiorgan involvement |
| Q47747732 | MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer |
| Q80508266 | Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival |
| Q43945429 | Microvillous inclusion disease: a clinicopathologic study of 17 cases from the UK. |
| Q21132368 | Molecular mechanisms underlying antiproliferative and differentiating responses of hepatocarcinoma cells to subthermal electric stimulation |
| Q40094787 | Optimization of immunolocalization of cell cycle proteins in human corneal endothelial cells. |
| Q36991284 | Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry. |
| Q33384726 | Proteomic analysis of RCL2 paraffin-embedded tissues. |
| Q39847963 | Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure. |
| Q38434374 | Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry |
| Q46837834 | The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma |
| Q26825604 | The scanning ion conductance microscope for cellular physiology |
Search more.